HSA Issues Urgent Warning Over Dangerous Weight-Loss Pills
The Health Sciences Authority (HSA) in Singapore has issued an urgent public warning regarding a product marketed as a weight-loss pill. Authorities discovered that the product contains a banned substance and several potent medicinal ingredients that could pose serious health risks to consumers.
The product, sold online, was found to contain sibutramine, a substance that was banned in Singapore in 2010. Sibutramine is known to increase the risk of heart attacks and strokes. Additionally, the pills contained other undeclared ingredients that could lead to severe side effects, including high blood pressure and heart palpitations.
HSA officials stated that the product was promoted on various social media platforms with false claims of rapid weight loss. These products are often manufactured in unregulated environments, meaning they do not meet the safety and quality standards required for medicine in Singapore.
Consumers are strongly advised to stop taking the product immediately and consult a doctor if they feel unwell. The HSA also reminded the public to be cautious when purchasing health products from unknown sources or websites that do not have a physical presence in Singapore.
Investigations into the sellers are currently ongoing. The authorities are working to remove these listings from online marketplaces to ensure the safety of the public. Residents are encouraged to report any suspicious health products to the HSA to prevent others from being harmed.